Sarah Raifman

Epidemiologist in training @UCSF_Epibiostat, #reprohealth and #EvidenceBasedPolicy researcher @ANSIRH. Views are my own.

[ANSIRH @ANSIRH]

Concerns that legal cannabis is associated with increased cannabis use during pregnancy or with changing beliefs about the safety of cannabis use during pregnancy are not supported by new findings. https://t.co/Va1nRoSOtC

[Sarah Raifman @seraifman]

I am proud to be one of 300+ researchers who signed on to this amicus brief reminding SCOTUS of the decades of evidence showing the safety and effectiveness of mifepristone — evidence that the FDA carefully reviewed before expanding access!

[Cathren Cohen (she/her) @CathrenCohen]

Today my colleagues and I @UCLAReproPolicy along with @PaulWeissLLP with support from @ANSIRH filed an amicus brief at the Supreme Court on behalf of over 300 leading reproductive health researchers urging the Court to preserve #mifepristone access.
https://t.co/nwGSWSQluc

[Sarah Raifman @seraifman]

Did you know that the abortion medication mifepristone is safer than penicillin, Viagra, and Tylenol? We summarized the ⁦@US_FDA⁩ ‘s latest safety data on mifepristone here. https://t.co/XOkILC5UPT

[Deb Karasek @karasekd]

Did SF’s paid parental policy improve birth outcomes? New work with @Julia__Goodman @seraifman @DrRitaHamad @WilliamHDow just published in @IJERPH, funded by @ucsfptbi. We found limited effects, likely b/c of inequitable access and that benefits are received after birth...1/2

[Dr. Daniel Grossman @DrDGrossman]

Today’s SCOTUS decision means that people who need abortion care will face even more barriers, stigma, and risk of criminalization. It goes against scientific evidence and its impact will be felt nationwide, particularly by people of color and those working to make ends meet.

[Sarah Raifman @seraifman]

Proud to be @ANSIRH and on the right side of history today.

[ANSIRH @ANSIRH]

We’re a research program at @UCSF that studies reproductive health, rights, and access.

We work hard to uncover the data so that policies can be research-driven.

Let’s be clear: Today’s SCOTUS decision contradicts scientific evidence. [ a thread 🧵]

[ANSIRH @ANSIRH]

Today, the Senate will vote on the Women’s Health Protection Act, which would safeguard abortion care from restrictions across the U.S. If enacted, #WHPA would protect this critical care, even if #RoevWade falls.

Here’s what the data says about why access to abortion matters.⬇️

[Sarah Raifman @seraifman]

@sjfbarnett Actually, Canada is way ahead of the US! Mifepristone has been available in Canada on normal prescription since 2017. https://t.co/xttwnFNiYf

[Sarah Raifman @seraifman]

👏 @DrDGrossman explains it all in his latest thread about the @US_FDA decision to make abortion pills available without in-person dispensing.

[Dr. Daniel Grossman @DrDGrossman]

All in all, the FDA’s decision today is good and mostly follows the evidence. But it could have gone farther—and just made prescribing mifepristone like any other medication that has risks and benefits…like they do in Canada. https://t.co/8kZlMj0QQk

[Ms. Magazine @MsMagazine]

The FDA has removed the long-standing in-person dispensing requirement for the abortion pill. What does this change mean for abortion access, and what barriers still remain? @ANSIRH's @seraifman breaks it down:
https://t.co/1bjulYmALe

[ANSIRH @ANSIRH]

The @US_FDA has recommended the permanent removal of its in-person dispensing requirement for mifepristone, one of two pills used for #medicationabortion.

ANSIRH's @seraifman outlines what this change means in @MsMagazine + what barriers still persist. https://t.co/Os6BmHRBld

[Sarah Raifman @seraifman]

The FDA considered the evidence and made a key decision to permanently allow pharmacies to dispense abortion pills yesterday. It’s not perfect, but it’s a wonderful start! Thanks ⁦@MsMagazine for publishing my op-ed on the decision. https://t.co/FcGHI56d59

[Sarah Raifman @seraifman]

Thank you, Justice Sotomayor.

[Sarah Raifman @seraifman]

Today I learned that my colleague, who lives in Texas, now commutes 9 hours to Oklahoma to provide abortion care. 80% of her patients there are Texans, including her neighbor who lives down the street from her. #SB8

[Sarah Raifman @seraifman]

This map is pathetic. Click on each country to see by what order of magnitude the US has fallen behind in terms of national #paidleave.

[Sarah Raifman @seraifman]

Also, for more about the mifepristone REMS, check out this video by my @ANSIRH colleague: https://t.co/nazeVMogla

[Sarah Raifman @seraifman]

We are finding that mail-order pharmacy dispensing of abortion pills is safe, effective, and well-liked by patients. ⁦
Check out our interim analysis ⁦@ContraceptionJL⁩ ! https://t.co/1qTiYxzJ3x

[Sarah Raifman @seraifman]

Pharmacists! Check out this FREE accredited continuing education module to learn about your essential current and future roles in the provision of medication abortion care … thanks @SallyRafie for leading the way! https://t.co/ZfCPNaAHGQ

[Amy Hagstrom Miller @AmyHM]

Our @WholeWomans team just finished care for our last patient in Texas today. I’m in awe of this amazing, dedicated team. Thank you. And now we wait……